{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:46:57Z","timestamp":1762004817770,"version":"3.37.3"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MINECO","award":["SAF2012-37979-C03-01"],"award-info":[{"award-number":["SAF2012-37979-C03-01"]}]},{"name":"FUNDELA"},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["AFM-16169"],"award-info":[{"award-number":["AFM-16169"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162723","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T17:49:50Z","timestamp":1473961790000},"page":"e0162723","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Small GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating Autophagy"],"prefix":"10.1371","volume":"11","author":[{"given":"Estefan\u00eda","family":"de Munck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valle","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Mu\u00f1oz-S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel I.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"G\u00f3mez-Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Teresa","family":"Solas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.","family":"Arahuetes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","article-title":"Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era","volume":"11","author":"X Paez-Colasante","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"ref2","first-page":"785","article-title":"Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study","volume":"260","author":"P Jennum","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5\u20136","key":"ref3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/21678421.2014.932382","article-title":"Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses","volume":"15","author":"M Gladman","year":"2014","journal-title":"Amyotrophic lateral sclerosis & frontotemporal degeneration"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clinthera.2014.12.020","article-title":"Therapeutic development in amyotrophic lateral sclerosis","volume":"37","author":"M Bucchia","year":"2015","journal-title":"Clin Ther"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13311-014-0332-8","article-title":"Challenges in the understanding and treatment of amyotrophic lateral sclerosis\/motor neuron disease","volume":"12","author":"J Rosenfeld","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"21","key":"ref6","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.15252\/embj.201490493","article-title":"Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS","volume":"34","author":"A Emde","year":"2015","journal-title":"EMBO J"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3390\/toxins2122837","article-title":"The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis","volume":"2","author":"SA Banack","year":"2010","journal-title":"Toxins (Basel)"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"A110","DOI":"10.1289\/ehp.120-a110","article-title":"The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?","volume":"120","author":"W Holtcamp","year":"2012","journal-title":"Environ Health Perspect"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13167-010-0019-0","article-title":"New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment","volume":"1","author":"RA Tasker","year":"2010","journal-title":"EPMA J"},{"issue":"5\u20136","key":"ref10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.lfs.2007.11.020","article-title":"Animal models of BMAA neurotoxicity: a critical review","volume":"82","author":"VT Karamyan","year":"2008","journal-title":"Life Sci"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1440-1789.2001.00361.x","article-title":"Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation","volume":"21","author":"N Shibata","year":"2001","journal-title":"Neuropathology: official journal of the Japanese Society of Neuropathology"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.etap.2015.04.022","article-title":"Morphometric and neurochemical alterations found in l-BMAA treated rats","volume":"39","author":"E de Munck","year":"2015","journal-title":"Environ Toxicol Pharmacol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.etap.2013.04.007","article-title":"beta-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS","volume":"36","author":"E de Munck","year":"2013","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuro.2015.04.001","article-title":"Analysis of beta-N-methylamino-L-alanine (L-BMAA) neurotoxicity in rat cerebellum","volume":"48","author":"E Munoz-Saez","year":"2015","journal-title":"Neurotoxicology"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01670.x","article-title":"Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord","volume":"85","author":"JH Hu","year":"2003","journal-title":"J Neurochem"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 proteinopathy and ALS: Insights into disease mechanisms and therapeutic targets","volume":"12","author":"EL Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer&apos;s disease","volume":"104","author":"C Hooper","year":"2008","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnmol.2011.00032","article-title":"GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS","volume":"4","author":"H Eldar-Finkelman","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brainres.2007.12.031","article-title":"Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci)","volume":"1196","author":"W Yang","year":"2008","journal-title":"Brain Res"},{"issue":"20","key":"ref20","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.2174\/092986711796391697","article-title":"The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy","volume":"18","author":"V Palomo","year":"2011","journal-title":"Curr Med Chem"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"e67433","DOI":"10.1371\/journal.pone.0067433","article-title":"Kinase inhibitor screening identifies cyclin-dependent kinases and glycogen synthase kinase 3 as potential modulators of TDP-43 cytosolic accumulation during cell stress","volume":"8","author":"D Moujalled","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.stem.2013.04.003","article-title":"A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS","volume":"12","author":"YM Yang","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"1\u20132","key":"ref23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2014.03.008","article-title":"Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis","volume":"340","author":"SW Ahn","year":"2014","journal-title":"J Neurol Sci"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/auto.7.4.14541","article-title":"Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"7","author":"X Zhang","year":"2011","journal-title":"Autophagy"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"RA Nixon","year":"2013","journal-title":"Nat Med"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"26797","DOI":"10.3390\/ijms161125990","article-title":"The Function of Autophagy in Neurodegenerative Diseases","volume":"16","author":"Y Kiriyama","year":"2015","journal-title":"International journal of molecular sciences"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2007.06.045","article-title":"Increased autophagy in transgenic mice with a G93A mutant SOD1 gene","volume":"1167","author":"N Morimoto","year":"2007","journal-title":"Brain Res"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/auto.5524","article-title":"Altered macroautophagy in the spinal cord of SOD1 mutant mice","volume":"4","author":"L Li","year":"2008","journal-title":"Autophagy"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/NEN.0b013e3182160690","article-title":"Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis","volume":"70","author":"S Sasaki","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4161\/auto.7.4.14700","article-title":"Targeting autophagy in ALS: a complex mission","volume":"7","author":"M Nassif","year":"2011","journal-title":"Autophagy"},{"issue":"1","key":"ref31","first-page":"121","article-title":"Protein clearing pathways in ALS","volume":"149","author":"M Ferrucci","year":"2011","journal-title":"Arch Ital Biol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1750-3639.2011.00546.x","article-title":"Autophagy dysregulation in amyotrophic lateral sclerosis","volume":"22","author":"S Chen","year":"2012","journal-title":"Brain Pathol"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/cn300110c","article-title":"Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo","volume":"3","author":"JA Morales-Garcia","year":"2012","journal-title":"ACS Chem Neurosci"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","article-title":"Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3","volume":"190","author":"E Beurel","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/adt.2006.029","article-title":"A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors","volume":"5","author":"A Baki","year":"2007","journal-title":"Assay Drug Dev Technol"},{"key":"ref36","unstructured":"ADP-Glo Kinase Assay Technical Manual. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.promega.com\/tbs\/\" xlink:type=\"simple\">www.promega.com\/tbs\/<\/ext-link>."},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"L Di","year":"2003","journal-title":"Eur J Med Chem"},{"issue":"3","key":"ref38","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"MC Alley","year":"1988","journal-title":"Cancer Res"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2013.07.010","article-title":"Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments","volume":"141","author":"MK King","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"15","key":"ref40","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2174\/15680266113139990138","article-title":"Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer&apos;s disease","volume":"13","author":"A Martinez","year":"2013","journal-title":"Curr Top Med Chem"},{"issue":"1\u20132","key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.05.038","article-title":"The neuroprotective effect of the GSK-3beta inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice","volume":"320","author":"SW Ahn","year":"2012","journal-title":"J Neurol Sci"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.expneurol.2007.03.004","article-title":"Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS","volume":"205","author":"SH Koh","year":"2007","journal-title":"Exp Neurol"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1021\/jm1016279","article-title":"Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds","volume":"54","author":"DI Perez","year":"2011","journal-title":"J Med Chem"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/jm500065f","article-title":"Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis","volume":"57","author":"IG Salado","year":"2014","journal-title":"J Med Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4236\/abb.2013.45083","article-title":"Evaluation of the effect of compound aqueous solubility in cytochrome P450 inhibition assays","volume":"4","author":"J P\u00e9rez","year":"2013","journal-title":"Adv Biosci Biotechnol"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"26797","DOI":"10.3390\/ijms161125990","article-title":"The function of autophagy in neurodegenerative diseases","volume":"16","author":"Y Kiriyama","year":"2015","journal-title":"International journal of molecular sciences"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/jm201463v","article-title":"5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3","volume":"55","author":"V Palomo","year":"2012","journal-title":"J Med Chem"},{"issue":"24","key":"ref48","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1021\/jm200996g","article-title":"Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities","volume":"54","author":"V Palomo","year":"2011","journal-title":"J Med Chem"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-0404.2008.01150.x","article-title":"Cyanobacterial neurotoxin BMAA in ALS and Alzheimer&apos;s disease","volume":"120","author":"J Pablo","year":"2009","journal-title":"Acta Neurol Scand"},{"issue":"19","key":"ref50","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1101\/gad.1830709","article-title":"XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy","volume":"23","author":"C Hetz","year":"2009","journal-title":"Genes Dev"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/156652411794474400","article-title":"The molecular machinery regulating apoptosis signal transduction and its implication in human physiology and pathophysiologies","volume":"11","author":"CT Hellwig","year":"2011","journal-title":"Curr Mol Med"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2011.09.081","article-title":"Cell death pathology: perspective for human diseases","volume":"414","author":"M Agostini","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4161\/auto.6.7.13042","article-title":"A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases","volume":"6","author":"V Crippa","year":"2010","journal-title":"Autophagy"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","article-title":"Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems","volume":"584","author":"VI Korolchuk","year":"2010","journal-title":"FEBS Lett"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T05:26:29Z","timestamp":1589693189000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162723"}},"subtitle":[],"editor":[{"given":"Anil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162723","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}